Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03260400 · ClinicalTrials.gov registry record · NA

Short-term Implanted Electrodes Following Regenerative Peripheral Nerve Surgery for Improving Prosthetic Limb Control Signals

A NA study of Amputation and Amputation Neuroma, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT03260400 is a NA study of Amputation and Amputation Neuroma that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 10 participants, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03260400, a NA study of Amputation and Amputation Neuroma, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The device, a bipolar percutaneous intramuscular electromyography electrode, is intended for use in upper-limb amputation patients who have received the regenerative peripheral nerve interface surgical procedure, in order to enable the use of advanced prosthetic arms and hands.

Interventions

  • DEVICE a bipolar percutaneous intramuscular electromyography electrode

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2017-12-11
Est. Completion 2029-05-05
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT03260400

The ClinicalTrials.gov registry entry for NCT03260400 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (92% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Amputation appearing as the primary indexed condition, and to 1 intervention - of which a bipolar percutaneous intramuscular electromyography electrode is the first listed.

NCT03260400 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT03260400 about?

NCT03260400 is a clinical study titled "Short-term Implanted Electrodes Following Regenerative Peripheral Nerve Surgery for Improving Prosthetic Limb Control Signals". The device, a bipolar percutaneous intramuscular electromyography electrode, is intended for use in upper-limb amputation patients who have received the regenerative peripheral nerve interface surgical procedure, in order to enable the use of advanced prosthetic arms and hands.

What is the current status of trial NCT03260400?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2017-12-11. Estimated completion is 2029-05-05.

What conditions does trial NCT03260400 study?

This clinical trial studies the following conditions: Amputation, Amputation Neuroma.

What interventions are being tested in trial NCT03260400?

The interventions under investigation include: a bipolar percutaneous intramuscular electromyography electrode (DEVICE).

Who is sponsoring clinical trial NCT03260400?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03260400 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.